Who we are
Viralgen is a CDMO born as a joint venture between Askbio and Columbus Venture Partners, combining decades of technology and drug development experience in multiple platforms to support best-in-class service offerings to the gene therapy market.
Viralgen was created in 2017 in response to the unmet need for manufacturing of gene therapies. Our goal was to help broaden the access to these life-saving therapeutics and contribute to the advancement of health and human welfare around the world.
We specialize in the production of rAAV viral vectors. Our optimized facility in San Sebastian, Spain maximizes throughput and efficiency of our proprietary Pro10™ suspension manufacturing platform. This enables industry-leading scalability, reproducibility, and speed to market.
Through our superior technology platform, we deliver industry-leading titers and cGMP-certified quality for all AAV serotypes to our client partners, optimize the cost-of-goods and accelerate clinical development and commercialization of life-saving genetic medicines.
Asklepios BioPharmaceutical, Inc. (AskBio) was founded in 2003 by Richard Jude Samulski, PhD, and Sheila Mikhail in Chapel Hill, North Carolina to take advantage of the deep gene therapy resources in the Research Triangle Park area. AskBio has since set the standard for gene therapy clinical development including a deep portfolio of intellectual property in gene therapy for multiple disease and an advanced manufacturing process.
AskBio has established and formed industry alliances for multiple spin out companies and continues to pursue new gene therapy technologies and treatments. Among those spin out are NanoCor Therapeutics (partnered with Medtronics to develop treatment for heart failure), Chatham Therapeutics (sold to Baxter to develop hemophilia treatments), and Bamboo Therapeutics (sold to Pfizer to develop cures for rare neuromuscular diseases and muscular dystrophy).
03About Columbus Venture Partners
Columbus Venture Partners is a Spanish investment Management Company with an investment strategy focused on the early-stage and high growth opportunities of biotechnology, medical technology, pharmaceuticals and healthcare industries in Spain. Its team of professionals combines a solid scientific, medical and business knowledge with an extensive experience in the establishment and investment of companies to accelerate merchandising.
The Columbus investment team has more than 75 years of professional experience with venture capital investments in pharmaceutical and biotechnology companies and invests through the COLUMBUS INNVIERTE Life Science Fund, FCR.
Javier García Cogorro
Chief Executive Officer
Almost 30 years of experience working in healthcare and the biopharmaceutical industry. Since 2009, Mr. Garcia has focused on life science venture capital investing, where he focuses on private company investments in the biopharmaceutical, life science and medical technology sectors. Mr. García received a bachelor's in mathematics (Statistics and Operations Research) from Universidad Complutense of Madrid and an MBA from ICADE (Spain).
César Trigueros, PhD
Chief Scientific Officer
Doctor in Molecular Biology. Over 20 years of leadership experience in the biotechnology field with special interest in gene therapy and immunology in both industry and academic settings.
Philippe Moullier, MD, PhD
Chief Scientific Officer Europe of Asklepios Biopharmaceutical (AskBio)
Joined Viralgen in May 2017 after working as collaborator of Bamboo Therapeutics from March 2015 through July 2016. Philippe Moullier was the founder and, until Dec 2016, the Director of the research INSERM Unit UMR 1089 entitled « Translational Gene Therapy for Retinal and Neuromuscular Diseases » at the University of Nantes, France. In January 2018, Philippe Moullier was appointed as Chief Development Officer at Viralgen VC in San Sebastian, Spain. Philippe also serves as the Chief Scientific Officer for Askbio Europe. His dual appointments allow the reinforcement of the US-Spanish strategic partnership.
Vice President, Business Development
Comes to Viralgen with more than a decade’s experience in biotech business development across the contract testing and manufacturing industries. He has worked with AAV companies bringing therapies to the clinic and market since 2008 and remains as passionate and awestruck about the power of this technology as he was when he first had a chance to be a part of it. A native of Atlanta, Georgia, he holds a BSc in Applied Biology from Georgia Tech and calls Raleigh, North Carolina home.
Kontxi San Juan
Human Resources Director
Highly experienced lawyer specialized in People Management. Over the past 25 years, she has worked on Team and Management Development, gaining expertise in a variety of international companies dedicated to various fields including the financial, industrial, health, distribution and aeronautics industries. She also has a strong academic foundation: a degree in law and a master’s degree in human resources. After searching for a company committed to human development where challenges are available, Kontxi comes to Viralgen as Human Resources Director to contribute to the business growth.